Verisure Q1 2026 Results

The company delivered a strong Q1 2026 performance, with ARR rising 12.2% year over year to €3,533m, revenue up 10.3% to €1,019m, and adjusted EBIT up 19.3% to €277m, lifting margin to 27.2%. It also generated positive free cash flow of €39m. Management reaffirmed full-year 2026 guidance, including ~10% ARR growth excluding Mexico, >26% adjusted EBIT margin, and positive free cash flow.

Analysis

The core read-through is not just “good quarter,” but a business that is now self-funding growth while expanding margin, which tends to re-rate a stock from value to quality compounding. The combination of >10% top-line growth and improving cash conversion suggests pricing power and low churn are offsetting any macro noise, while the positive free cash flow removes the usual capex/working-capital skepticism that keeps subscription/recurring-revenue names discounted. In other words, this is the kind of print that can compress the equity risk premium for the whole cohort, not just the company itself.

The second-order effect is on competitors with weaker unit economics: if one scaled operator can grow ARR mid-teens while lifting EBIT margin, smaller peers will be forced to choose between retention spend and margin defense. That usually shows up over the next 1-2 quarters as higher sales efficiency pressure, more aggressive discounting in renewals, or slower net retention for the weaker names. The explicit exclusion of Mexico from the growth target matters because it implies the underlying core business is already strong enough to absorb a known tailwind rollback and still guide confidently.

The main risk is that this remains a sentiment- and multiple-sensitive story: if growth decelerates even modestly after a strong comp, the market can punish the stock despite the cash flow improvement. Over the next 3-6 months, the key catalyst is whether the company can repeat margin expansion without leaning on one-offs; over 12 months, the test is whether ARR growth stays in the low-teens as the installed base matures. If that slips below the guided range, the valuation reset would likely be sharper than the upside rerating from this quarter.

Key Decisions for Investors

• Long the stock on any post-earnings pullback: best entry is after the initial gap is digested, with a 3-6 month horizon and a target of multiple expansion if the market re-prices it as a durable compounder.
• Pair trade: long this high-quality recurring revenue name vs. a lower-margin software/services peer with similar growth but weaker FCF conversion; expect relative outperformance if investors continue to reward cash-backed growth.
• If options are available, buy 3-6 month call spreads rather than outright calls to express upside on continued execution while limiting vega risk if the market rotates away from growth.
• For holders, trail stops only if ARR growth drops meaningfully below guided levels for two consecutive quarters; that would be the first signal that the margin expansion is not structurally sustainable.